BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
2.130
-0.170 (-7.39%)
At close: Feb 21, 2025, 4:00 PM
2.260
+0.130 (6.10%)
After-hours: Feb 21, 2025, 6:54 PM EST
BioXcel Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Feb '25 Feb 21, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 7 | 86 | 602 | 569 | 1,126 | 263 | |
| Market Cap Growth | -66.43% | -85.65% | 5.82% | -49.47% | 327.27% | 336.30% | |
| Enterprise Value | 71 | 96 | 462 | 317 | 895 | 225 | |
| Last Close Price | 2.13 | 47.20 | 343.68 | 325.28 | 739.20 | 233.76 | |
| PS Ratio | 2.09 | 62.58 | 1605.17 | - | - | - | |
| PB Ratio | -0.08 | -1.53 | 7.84 | 2.57 | 5.45 | 9.80 | |
| P/TBV Ratio | - | - | 7.84 | 2.57 | 5.45 | 9.80 | |
| EV/Sales Ratio | 31.28 | 69.82 | 1233.33 | - | - | - | |
| Debt / Equity Ratio | -1.23 | -1.79 | 1.22 | 0.00 | 0.01 | 0.04 | |
| Asset Turnover | 0.03 | 0.01 | 0.00 | - | - | - | |
| Inventory Turnover | 1.14 | 0.63 | - | - | - | - | |
| Quick Ratio | 1.58 | 2.39 | 5.90 | 13.98 | 18.00 | 3.83 | |
| Current Ratio | 1.87 | 2.65 | 6.17 | 14.21 | 18.33 | 4.03 | |
| Return on Equity (ROE) | - | -1766.94% | -111.08% | -49.93% | -70.35% | -100.23% | |
| Return on Assets (ROA) | -62.12% | -74.95% | -44.81% | -29.10% | -40.13% | -52.54% | |
| Return on Capital (ROIC) | -117.90% | -97.23% | -50.73% | -31.02% | -43.59% | -62.86% | |
| Earnings Yield | -1074.58% | -207.35% | -27.54% | -18.80% | -7.30% | -12.51% | |
| FCF Yield | -1272.63% | -179.52% | -22.51% | -14.52% | -5.92% | -10.62% | |
| Buyback Yield / Dilution | -24.19% | -3.98% | -6.23% | -21.63% | -33.11% | -11.79% | |
| Total Shareholder Return | -24.19% | -3.98% | -6.23% | -21.63% | -33.11% | -11.79% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.